Literature DB >> 26825355

A Patient With Atypical Multiple Sulfatase Deficiency.

Chandrabhaga Miskin1, Joseph J Melvin1, Agustin Legido1, David A Wenger2, Sue Moyer Harasink1, Divya S Khurana3.   

Abstract

BACKGROUND: Multiple sulfatase deficiency is an autosomal recessive lysosomal storage disorder characterized by the absence of several sulfatases and resulting from mutations in the gene encoding the human C (alpha)-formylglycine-generating enzyme. There have been a variety of biochemical and clinical presentations reported in this disorder. PATIENT DESCRIPTION: We present a 4-year-old girl with clinical findings of microcephaly, spondylolisthesis and neurological regression without ichthyosis, coarse facies, and organomegaly.
RESULTS: The child's magnetic resonance imaging demonstrated confluent white matter abnormalities involving the periventricular and deep cerebral white matter with the U-fibers relatively spared. Biochemical testing showing low arylsulfatase A levels were initially thought to be consistent with a diagnosis of metachromatic leukodystrophy. The diagnosis of multiple sulfatase deficiency was pursued when genetic testing for metachromatic leukodystrophy was negative.
CONCLUSION: This child illustrates the clinical heterogeneity of multiple sulfatase deficiency and that this disorder can occur without the classic clinical features.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  leukodystrophy; multiple sulfatase deficiency; neurological regression

Mesh:

Substances:

Year:  2015        PMID: 26825355     DOI: 10.1016/j.pediatrneurol.2015.10.023

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  2 in total

1.  Pitfalls in Genetic Testing for Consanguineous Pediatric Populations.

Authors:  Maha Saleh; Samantha Colaiacovo; Melanie P Napier; Asuri N Prasad; C Anthony Rupar; Chitra Prasad
Journal:  Case Rep Genet       Date:  2022-05-25

2.  Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement.

Authors:  Rebecca Ahrens-Nicklas; Lars Schlotawa; Andrea Ballabio; Nicola Brunetti-Pierri; Mauricio De Castro; Thomas Dierks; Florian Eichler; Can Ficicioglu; Alan Finglas; Jutta Gaertner; Brian Kirmse; Joerg Klepper; Marcus Lee; Amber Olsen; Giancarlo Parenti; Arastoo Vossough; Adeline Vanderver; Laura A Adang
Journal:  Mol Genet Metab       Date:  2018-01-31       Impact factor: 4.797

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.